A practical, Europe-focused guide to research chemical risks in 2026 — covering toxicity, dosing uncertainty, contamination, legal exposure, and evidence-based harm reduction for laboratory and research professionals.
Tag Archives: NPS Europe
Understanding how research chemicals interact with the brain is essential for anyone working with novel psychoactive substances in a laboratory context. This guide explains the core neurotransmitter systems involved, how receptor binding and reuptake inhibition shape pharmacological profiles, why structural tweaks can produce dramatically different effects, and where the scientific data still falls short.
Novel psychoactive substances (NPS) have reshaped the European research chemical landscape. This guide explains what NPS are, how they differ from traditional research chemicals, their pharmacology and health risks, and how EU regulations are evolving to address them.